Sandrine Flory
Director/Board Member at TRANSGENE
Profile
Sandrine Flory is currently a Director at Transgene SA, TSGH SAS, GeNeuro SA (Switzerland), and Institut Mérieux SA. She previously worked as the Chief Financial Officer-EMEA Division at bioMérieux SA. Ms. Flory holds a graduate degree from Universite Lumiere Lyon 2.
Sandrine Flory active positions
Companies | Position | Start |
---|---|---|
TRANSGENE | Director/Board Member | 01/01/2021 |
GENEURO SA | Director/Board Member | 18/03/2024 |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Director of Finance/CFO | 01/01/2020 |
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Director/Board Member | 01/01/2002 |
Former positions of Sandrine Flory
Companies | Position | End |
---|---|---|
BIOMÉRIEUX | Corporate Officer/Principal | 01/01/2020 |
Training of Sandrine Flory
Universite Lumiere Lyon 2 | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
TRANSGENE | Health Technology |
BIOMÉRIEUX | Health Technology |
GENEURO SA | Health Technology |
Private companies | 2 |
---|---|
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Finance |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
- Stock Market
- Insiders
- Sandrine Flory